Next Article in Journal
MIL-88A Metal-Organic Framework as a Stable Sulfur-Host Cathode for Long-Cycle Li-S Batteries
Previous Article in Journal
Synthesis of Three-Dimensional Carbon Nanostructure/Copper Nanowire for Additive Interface Layer of Ionic Polymer Metal Composite
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nanomaterials
Volume 10
Issue 3
10.3390/nano10030422
nanomaterials-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effective Inhibition of Candidiasis Using an Eco-Friendly Leaf Extract of Calotropis-gigantean-Mediated Silver Nanoparticles

by
Enas M. Ali
1,2 and
Basem M. Abdallah
1,*
1
Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia
2
Department of Botany and Microbiology, Faculty of Science, Cairo University, Cairo 12613, Egypt
*
Author to whom correspondence should be addressed.
Nanomaterials 2020, 10(3), 422; https://doi.org/10.3390/nano10030422
Submission received: 4 February 2020 / Revised: 20 February 2020 / Accepted: 25 February 2020 / Published: 28 February 2020
(This article belongs to the Section Biology and Medicines)
Browse Figures
Versions Notes

Abstract

:
The approaches used for the green biosynthesis of nanoparticles with clinical applications have been widely used in nanotechnology due to their potential to provide safe, eco-friendly, cost effective, high-stability, and high-loading-capacity nanoparticles. This study aimed to evaluate the anti-candidal activity of silver nanoparticles (AgNPs) biosynthesized using the aqueous leaf extract of Calotropis gigantea (CG) alone or in a combination with the plant extract of CG (AgNPs/CG). AgNPs were characterized using UV-Vis spectrophotometry, Fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), and X-ray diffraction (XRD). The results of the standard disk diffusion method revealed that AgNPs alone displayed anti-candidal activity (11.33-mm inhibition zone), while AgNPs/CG displayed a strong synergistic anti-candidal activity (17.76-mm inhibition zone). Similarly, AgNPs/CG completely inhibited the growth of C. albicans after 4 h of incubation, as measured using the time-kill assay. In addition, AgNPs/CG inhibited the dimorphic transition of C. albicans and suppressed both the adhesion and the biofilm formation of C. albicans by 41% and 38%, respectively. The treatment of Candida. albicans with AgNPs/CG showed a significant inhibition of the production of several antioxidant enzymes. Interestingly, AgNPs/CG did not show any cytotoxicity in animal cells, including the MCF-7 cell line and primary mouse bone marrow-derived mesenchymal stem cells (mBMSCs), at the concentration used to completely inhibit the dimorphic transition of C. albicans. In conclusion, we identified AgNPs/CG as a promising natural-product-based nanoparticle that can potentially be used as an anti-candidal drug.

1. Introduction

Candida albicans is a member of the human gut flora and is also an opportunistic pathogenic yeast [1]. C. albicans, together with other species of Candida, such as C. tropicalis, C. parapsilosis, and C. glabrata, are responsible for approximately 50–90% of all cases of candidiasis in humans [2]. C. albicans is identified as one of the most common agents responsible for invasive candidiasis and its infection causes a mortality rate of 40% for patients with systemic candidiasis. Invasive candidiasis contracted in a hospital setting could cause up to 11,200 deaths annually in the United States [3]. C. albicans can be found in the oral cavity of 75% of the population. In immunocompromised individuals, it can cause recalcitrant infections of the oral cavity termed oral candidiasis. Approximately 75% of all women suffer at least once in their lifetime from vulvovaginal candidiasis, with 40%–50% experiencing at least one additional episode of infection [4].
A wide range of virulence factors supports the infection ability of C. albicans, including the morphological transition between yeast and hyphal forms (phenotypic switching), and the expression of adhesions and invasions in the cell surface and the secretion of hydrolytic enzymes. The formation of biofilms also plays an important role in pathogenesis, where cells in a biofilm display a higher resistance to antifungal drugs because of the improper penetration of antifungal agents [5]. Consequently, the inhibition of biofilm formation and dimorphic transition are considered effective strategies for controlling the virulence and pathogenicity of C. albicans and form the basis for development of anti-fungal drugs [6]. Additionally, the effectiveness of current antifungal drugs is limited due to the emergence of resistant Candida biofilms and their toxicities [7].
Recently, great attention has been paid to the production of nanoparticles as an antimicrobial drug to be used either alone or in combination with current traditional drugs. In this context, the antimicrobial action of bio-factorized AgNPs with promising therapeutic effects was reported in many studies [8,9]. The green synthesis of nanoparticles by biological methods using plants has shown numerous advantages, including low costs and the large-scale production of nanoparticles, as well as being environmentally safe [10]. On the other hand, nanoparticle production using physical methods demands high energy consumption and chemical methods produce hazardous and toxic compounds that reduce the biological applications of generated nanoparticles [11]. In this study, we used C. gigantea L. (Asclepiadaceae) for the green synthesis of AgNPs due to its multiple reported therapeutic potentials, including anti-inflammatory, analgesic, anticonvulsant, anxiolytic, sedative, antidiarrheal, antipyretic, and antimicrobial effects [12,13]. In addition, leaves and areal parts of the plant were reported to have anti-bacterial, anti-fungal [14], and anti-oxidant activities [15]. Due to its wide range of bioactivities, crude aqueous extracts of C. gigantea have previously been used for the green synthesis of nanoparticles, including AgNPs and CuO NPs, which have shown remarkable anti-bacterial activity and applications in dye-sensitized solar cells, respectively [16,17,18]. In this study, we investigated for the first time the anti-candidal activity of combined green synthesized AgNPs with C. gigantea plant extracts (AgNPs/CG) against C. albicans. Our data demonstrated for the first time the superior anti-microbial potential of AgNPs/CG over AgNPs alone in inhibiting C. albicans growth via suppressing the dimorphic transition, anti-oxidant enzymes, and biofilm formation, with no sign of cytotoxicity on cultured animal cells.

2. Materials and Methods

2.1. Chemicals

Nutrient agar, sabouraud dextrose agar (SDA), Sabaroud dextrose broth (SDB), RPMI-1640 medium, amphotericine b, dimethyl sulphoxide (DMSO), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), phenylmethylsulphonyle fluoride (PMSF), sucrose, 1-chloro-2,4-dinitrobenzene (CDNB), glutathione, hydrogen peroxide (H2O2), were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA).

2.2. Plant Collection

Leaves of C. gigantea were collected from shudqum (Al Hassa–El Dammam Road), Eastern Providence, Saudi Arabia. The plant was classified at the Cairo University herbarium. Herbarium samples (voucher number S6E8) were kept at the Department of Botany and Microbiology, Cairo University. The plants were allowed to air-dry at room temperature, then leaves were ground into powder and stored for further experiments.

2.3. Test Organism and Growth Conditions

The C. albicans strain used in this study was isolated and identified by our group as previously described [19] (Figure 1A), and kept on Sabouraud’s glucose agar slopes at 4 °C. Inoculates were prepared from cultures on Sabouraud’s agar slopes incubated at 37 °C for 16–18 h. The yeast cells were washed in sterile water, centrifuged, and re-suspended in water (under aseptic conditions). The number of blastospores/mL of suspension were determined using hemocytometer counting and a suitable volume of suspension was added to 250 mL Erlenmeyer flasks containing 100 mL of broth to yield an initial concentration of 106/mL blastospores.

2.4. Preparation and Characterization of AgNPs

2.4.1. Preparation of the Leaf Extract

Fresh leaves were washed with distilled water, then cut into small pieces and allowed to dry at room temperature. Ten grams of leaves were boiled in 100 mL distilled water for 20 min and filtered through Whatman No. 1 filter paper [20].

2.4.2. Biosynthesis of AgNPs

An aqueous solution (1 mM) of silver nitrate (AgNO3) was mixed with leaf extract. The mixture was kept in a microwave oven at 300 W for 4 min to complete the bio-reduction of AgNO3 to Ag+ ions. Complete reduction was confirmed by changing the color from colorless to colloidal brown and saturation was detected using UV-visible spectrophotometric scanning with an Agilent 8453 spectrophotometer (Santa Clara, CA, USA) [20].

2.4.3. Transmission Electron Microscopy (TEM)

TEM was performed according to the method of Teranishi et al. [21] on a Leo 912 AB instrument (Aalen, Germany). Briefly, a drop of diluted sample of AgNPs was poured onto carbon-coated copper grids and allowed to stand for 2 min before imaging.

2.4.4. X-ray Diffraction Analysis (XRD)

The lyophilized AgNPs coated on an XRD grid were exposed to XRD measurements. The analysis was carried out in an X-ray diffractometer with an operating voltage of 45 kV and a current of 0.8 mA (Unisantis XMD-300, Geneva, Switzerland). The diffraction patterns were found using Cu-Kα radiation of wavelength 1.54 Å in the region of 2θ from 30° to 80° [22].

2.4.5. Fourier Transform Infrared Spectroscopy (FTIR)

The aqueous leaf extract and AgNPs were subjected to FTIR spectroscopy (Thermo Nicolet AVATAR 370, Waltham, MA, USA) to examine their spectra. The analysis was done with KBr pellets, recorded in the range of 500–4000 cm−1 [22].

2.5. Anti-Candidal Activity

A disk diffusion method was used to evaluate the anti-candidal activity of AgNPs and AgNPs/CG, as described previously [23]. Prior to use, the solution of AgNPs was prepared via dissolving AgNPs in 5% dimethylsulfoxide (DMSO, 1000 µg/mL). The sample was sonicated for 15 min and sterile filter paper disks containing 50 µg of AgNPs/disk were used for the assay. A standard antifungal agent, amphotericine b, at 5 µg/disk was used as a positive control, while 5% DMSO was used as a negative control. For the preparation of AgNPs/CG: AgNPs (50 µg/mL) and plant extract (200 µg/mL) were mixed and sonicated for 15 min at room temperature. Paper disks were prepared by adding 50 µL of the AgNPs/CG mixture solution to a 6-mm filter paper disk that contained 50 µg AgNPs and 5 µg amphotericin b. The culture of C. albicans was diluted to 1 × 106 CFU and the anti-candidal activity of the AgNPs and AgNPs/CG were evaluated by measuring the diameter of inhibition zones after 48 h of incubation at 28 °C. The minimum inhibitory concentration (MIC) of the AgNPs and AgNPs/CG were determined using the bi-fold serial dilution method [24]. Different concentrations of AgNPs and plant extract (6.25–400 µg/mL) were used for the MIC assay. MIC values were expressed as µg/mL.

2.6. Time-Kill Assays

The anti-candidal activities of AgNPs and AgNPs/CG were evaluated at 0, 4, 8, and 10 h using a colony-counting method. At the determined time, an aliquot of 30 μL was taken from each test suspension and inoculated into SDA for quantifying the colony forming units. Sabaroud dextrose broth (SDB) without any antifungal agent was used as a control [25].

2.7. Assay of C. albicans Hyphal Development in Liquid Media

Cultures of C. albicans grown overnight were inoculated at 37 °C for 24 h with shaking in RPMI-1640 medium (hyphae-inducing media) supplemented with either amphotericin b, AgNPs, or AgNPs/CG. RPMI-1640 medium without any antifungal agent was used as a control. Aliquots of fungal cells were harvested after 24 h and examined using a bright field with Digital Cell Imaging System (Logos Bio Systems, Heidelberg, Germany) [26].

2.8. Adhesion and Biofilm Formation Assays

C. albicans suspensions (1 × 106 cells/mL) were inoculated in RPMI-1640 medium supplemented with 0.25% glucose and added to 96 microtiter plates (Nunc, Roskilde, Denmark). AgNPs, plant extract, and AgNPs/CG were added separately to cultured C. albicans and incubated for 2 h (to measure adhesion) and 24 h (to measure biofilm formation) at 37 °C under static conditions. After incubation, non-adherent cells were removed via washing and the wells were washed. Biofilm growth was measured using an MTT metabolic assay [27]. Wells without any antifungal agent were used as controls, while those without biofilms were the blanks.

2.9. Determination of Antioxidant Enzymes

C. albicans was grown overnight at 37 °C in the presence of AgNPs/CG. Cells were harvested and homogenized in a homogenizing buffer (1 mmol/L phenylmethylsulphonyle fluoride, 250 mmol/L sucrose, 10 mmol/L Tris–HCl, pH 7.5). The cells were then disrupted at 4 °C using a soniprobe. The homogenate was centrifuged at 20,217× g for 1 h at 4 °C. The protein concentration was evaluated using the Lowry method [28] and the antioxidant enzyme activities were determined as follows. Glutathione S-transferase (GST) activity was measured spectrophotometrically through determining the glutathione (GSH) and 1-chloro-2,4-dinitrobenzene (CDNB) conjugates at 340 nm according to the method of Chitme et al. [29]. Catalase (CAT) activity was evaluated by quantifying the decrease in absorbance of hydrogen peroxide at 240 nm according to the method of Kumar et al. [30]. Superoxide dismutase (SOD) activity was measured using the adrenochrome test, which is dependent on the capability of SOD to suppress the autoxidation of epinephrine in alkaline conditions using the method of Lhinhatrakool and Sutthivaiyakit [31]. Glutathione reductase (GSR) activity was evaluated following the method described by [32], where one unit of glutathione reductase activity is known as the amount of the enzyme catalyzing the reduction of 1 μM of NADPH per min. Glucose 6 phosphate dehydrogenase (G6-P) activity was measured by quantifying the reduction of NADP at 340 nm following the previous method of Gupta and Sanjrani [33]. The activity of glutathione peroxidase (GPX) was determined by measuring a decrease in absorbance at 340 nm, suggestive of the disappearance of NADPH as described [32]. The reaction was initiated by the addition of hydrogen peroxide and the enzyme activity was calculated as nanomoles of NADPH oxidized per minute per milligram protein by using a molar extinction coefficient of 6.22 × 103 mol L−1 cm−1.

2.10. Transmission Electron Microscopy

The aliquots from non-treated cells (control) and treated cells were washed, fixed in a solution of 2.5% glutaraldehyde in 0.1 M cacodylate buffer (Sigma), and then washed in 0.1 M cacodylate buffer at pH 7.2. The samples were then post-fixed in 2.0% osmium tetroxide in 0.1 M cacodylate buffer at pH 7. The samples were dehydrated in a series of alcohol and placed in acetone. Infiltration and embedding were done in Epon-812 resin (EMBed-812 Embedding Kit, catalog no. 14120, Electron Microscopy Sciences, Hatfield, PA, USA). Sections were cut with a Porter Blum MT-2 ultra-microtome (Sorval, Liverpool, NY, USA) using glass and diamond blades. Ultrathin sections were compared in a solution of 2.0% uranyl acetate and lead nitrate/acetate. Samples was examined under a JEOL 1200EX II transmission electron microscope (Peabody, MA, USA) [34].

2.11. Cell Culture

Primary mouse BMSCs were isolated from sacrificed 8-week-old male C57BL/6J mice, as previously described [35]. In brief, bone marrow was flushed out from mouse tibia and femurs using BPS and collected in Eppendorf tubes. Bone marrow cells were isolated using centrifugation for 1 min at 400× g. Cells were purified via filtration through a 70-μm nylon mesh filter and cultured in 60 cm2 flasks in RPMI-1640 medium supplemented with 12% FBS (Gibco Invitrogen, Dreieich, Germany), 1% penicillin/streptomycin (P/S) (Gibco Invitrogen), and 12 μM L-glutamine (Gibco Invitrogen) in a 5% CO2 incubator at 37 °C. The non-adherent cells were removed after 6 h and cultured in fresh medium. The medium was changed every 3–4 days and BMSCs were maintained to be subcultured at a split ratio of 1:2.
A human breast adenocarcinoma MCF-7 cell line was obtained from Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures (ACC 115, Braunschweig, Germany) [36]. Cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin (P/S), and 10 µg/mL insulin (Gibco Invitrogen).

2.12. Cytotoxicity Assay

The cytotoxicity of different compounds was determined by measuring the cell viability using an MTT cell proliferation assay kit (Sigma-Aldrich) according to the manufacturer’s instructions. The cells were seeded in 96-well plates and treated with different concentrations of either AgNPs or AgNPs/CG for 48 h. The cells were then washed with PBS and incubated with fresh medium containing 0.5 mg/mL MTT to metabolize to formazan. The optical density was determined at 550 nm using an ELISA plate reader [37]. Cell viability was represented as a percentage of the control non-treated cells.

2.13. Statistical Analysis

All values are represented as mean ± SD, of at least three independent experiments. A power calculation was performed for two-samples using an unpaired Student’s t-test (two-tailed) assuming equal variation in the two groups. Differences were considered statistically significant at * p < 0.05, and ** p < 0.005.

3. Results

3.1. Preparation and Characterization of AgNPs

In the present study, aqueous leaf extract of C. gigantea, a traditional medicinal plant, was used as a reducing and stabilizing agent for the green synthesis of AgNPs. The ability of the bioactive components of C. gigantea to act as biocatalysts for the reduction of Ag+ to Ag0 was evaluated. The change of color of the biomass filtrate after adding AgNO3 as a precursor from colorless to yellowish brown was observed (Figure 1B). The UV-visible spectra of biosynthesized AgNPs showed an absorption band peaking at 450 nm (Figure 2A). The color of the solution supports the absorption wavelength in the visible region. The XRD pattern showed clear diffraction line at low angles (30°–80°). The Bragg reflections at angles 2θ of 38.18°, 44.35°, 64.4°, and 77.3° corresponded to the 111, 200, 220, and 311 bands, respectively (Figure 2B). This pattern verified the structure of AgNPs as a face-centered cubic structure. XRD results confirmed the crystal structure of the silver in the C. gigantean extract. The FTIR spectrum of biosynthesized AgNPs displayed seven different peaks: 1116, 1457, 1629, 2361, 2853, 2923, and 3421 cm−1 (Figure 3A). The peaks at 3421cm−1 and 2923 cm−1 were due to the NH stretch vibration of the primary and secondary amides of protein. The peak at 2853 cm−1 was due to the C–H symmetrical stretch vibration of alkanes. The peak at 2361 cm−1 was due to the primary amine group of proteins. The peaks at 1457 cm−1 was due to the amino and amino-methyl stretching groups of proteins. The peak at 1116 cm−1 was due to the C–O stretching vibrations mode. Finally, TEM gave additional information about the morphology, size, and distribution profile of the AgNPs. The results obtained from the TEM demonstrated that the biosynthesized AgNPs were spherical in shape and the size was in the range of ≈10–70 nm (Figure 3B). In addition, AgNPs were distributed uniformly without significant agglomeration.

3.2. Anti-Candidal Activity of AgNPs

We studied the anti-candidal activity of AgNPs, C. gigantea plant extract, and AgNPs/CG using a disk diffusion method assay. In this assay, the commercially available amphotericin b showed a higher inhibitory effect against C. albicans with an inhibition zone diameter of 19 mm. The AgNPs showed a moderate anti-candidal activity with inhibition zone diameter of 11.33 mm, while the plant extract displayed a lower anti-candidal activity with an inhibition zone diameter of 6.1 mm (Table 1 and Figure 4A). The MIC values of AgNPs and plant extract were 50 and 200 µg/mL, respectively (Table 1).

3.3. Synergistic Anti-Candidal Activity of AgNPs and Plant Extract

When AgNPs were combined with the plant extract, they exhibited a synergistic anti-candidal action against C. albicans, with a zone of inhibition of 17.22 mm (Table 1 and Figure 4A). In addition, the time-kill curves measured the fungi-static effect for both AgNPs and plant extract at 50 μg/mL and 200 μg/mL, respectively, on the growth of Candida cells (Figure 4B). After only 4 h of incubation, AgNPs/CG inhibited the growth of C. albicans to zero colonies in contrast to the plant extract alone or AgNPs alone samples, which still had live colonies (Figure 4B). Thus, AgNPs/CG displayed a higher anti-candidal activity than either AgNPs alone or plant extract alone.

3.4. Effect of AgNPs/CG on the Virulence Factors of C. albicans

As shown in Figure 5A, the untreated controls displayed great hyphal growth after 6 h, while the capacity of C. albicans to transform morphologically was repressed by AgNPs at concentrations lower than the MIC. On the other hand, hyphal growth was totally blocked in the presence of AgNPs/CG (50 μg/mL AgNPs + 200 μg/mL plant extract), as assessed using microscopic observations. In addition, we examined the anti-adhesive and anti-biofilm efficiencies of the AgNPs, plant extract, or AgNPs/CG. As shown in Figure 5B,C, AgNPs (50 μg/mL) inhibited the adhesion and the biofilm growth of C. albicans by 59% and 53%, respectively, while AgNPs/CG inhibited the adhesion and biofilm formation of C. albicans by 91% and 87%, respectively (Figure 5B,C).

3.5. AgNPs/CG Suppressed the Production of Antioxidant Enzymes by C. albicans

Since, very little is known about the inhibition of the production of oxidative enzymes by nanoparticles, we measured the effect of AgNPs/CG on the production of antioxidant enzymes by C. albicans. Interestingly, AgNPs/CG showed the ability to significantly inhibit the following anti-oxidant-related enzymes, including GST, CAT, SOD, G6-P, GSR, and GPX by 85.73%, 86.92%, 83.33%, 87.50%, 85.71%, and 100% respectively in C. albicans (Table 2).

3.6. Morphological and Ultrastructural Alteration Caused by AgNPs/CG

We further examined the effect of AgNPs/CG on the ultrastructural alteration of C. albicans using TEM. Non-treated cells showed the typical filamentous morphology of C. albicans, which was very elongated but narrow in width (0.6–1.1 µm) (Figure 6A). A septum was formed between new filamentous growth and the parent cell, and the cell wall thickness was thinner than that of the yeast-phase cells. In contrast, cells treated with AgNPs/CG showed the typical C. albicans yeast form morphology, where the ovoid cell was surrounded by a cell wall. Within the cytoplasmic area, slightly irregular organelles (such as nucleus, mitochondria, endoplasmic reticulum, and nuclei) were found to be frequently ovoid, and a double-unit membrane enclosed them. Mitochondria were elongated (Figure 6B).

3.7. Cytotoxicity of AgNPs/CG

As a preliminary step to examine the therapeutic effect of AgNPs/CG in vivo, we examined the cytotoxicity of AgNPs/CG on the human cancer cell line MCF-7 and primary mouse BMSCs using a cell viability MTT assay. As demonstrated in Figure 7A,B, AgNPs showed a cytotoxicity at concentrations above 100 µg/mL, while the plant extract was not toxic to the cells up to 300 µg/mL. Interestingly, AgNPs/CG displayed cytotoxicity at concentration above 200 µg/mL plant extract + 50 µg/mL AgNPs and started to be toxic for both cell types at 500 µg/mL plant extract + 50 µg/mL AgNPs (Figure 7C).

4. Discussion

The biosynthesis of nanoparticles by plants could be a better candidate for the low-cost and large-scale production of nanoparticles due to it being environmentally safe [38]. C. gigantea is a common medicinal plant reported as having anti-candidal activity, cytotoxic activity, antipyretic activity, and wound healing activity [14,39]. Numerous compounds have been extracted from C. gigantea, such as cardenolides [40], flavonoids [41], and giganticine [42]. In our study, the appearance of a brown color in the reaction solution was a clear indication of the formation of AgNPs in the reaction mixture, as described previously [43,44]. The characterization of the green synthesized AgNPs using the aqueous leaf extract of C. gigantea was achieved using techniques such as UV-vis spectroscopy, FTIR analysis, TEM, and XRD analysis [45,46]. The surface plasmon resonance phenomena (SPR) absorbance is sensitive to the shape, size, and nature of particles present in the solution, and also depends upon the inner particle distance and the surrounding media. Spectral analysis revealed the SPR absorption of our green synthesized AgNPs at 450 nm, which was within the typical wavelengths (from 400 to 480 nm) reported for AgNPs [47,48].
Our data identified the MIC for AgNPs to be 0.05 mg/mL with a high anti-candidal activity. AgNPs produced using different methods display variable levels of antifungal action based on their size, shape, and surface modification [49,50,51,52]. In this regard, several studies investigated the antimicrobial activity of AgNPs. For example, synthesized AgNPs using the seed extract of Syzygium cumini displayed anti-candidal activity at 0.125–0.250 mg/mL [8], while AgNPs biosynthesized using Artemisia annua leaf extracts displayed fungicidal action against three clinically important Candida species at 120 mg/mL [53].
Several mechanisms were reported to explain the mode of anti-candidal activity of AgNPs. These include the capacity of AgNPs to damage the membrane permeability barrier and to destruct the membrane lipid bilayers, resulting in the leakage of ions, along with forming pores and dissipating the electrical potential of the membrane. In addition, AgNPs were shown to block the cell cycle at G2/M phase in C. albicans [54], to increase the production of reactive oxygen species (ROS), and to decrease the activity of metal-based antioxidant enzymes [55].
In this study, we demonstrated that the efficiency of the antifungal activity of AgNPs could be enhanced via the combination therapy of AgNPs with natural antifungal agents to provide a novel strategy for the efficient control of C. albicans. To our knowledge, this was the first report to identify the MIC value of a combination between a plant extract and its biosynthesized AgNPs against C. albicans. Previously, the anti-candidal action of AgNPs was found to be improved using a combination with commercially available amphotericin b against five Candida species [23]. Thus, our data identified C. gigantea leaf extract as a source of bioactive antifungal compounds that could contribute in the extracellular synthesis of AgNPs, and has a stronger antifungal action than the previously designated antifungal effect [14,56,57].
The phenotypic switching between yeast and hyphal forms has been considered as one of the most significant virulent factors in C. albicans [58]. The development of hyphae is an interesting property of C. albicans that plays a vital role in adherence and biofilm formation, which is certainly crucial for colonization and pathogenesis [59,60]. The blocking of morphogenesis from yeast to a filamentous form would mean preventing the infection. Our data demonstrated the blocking of hyphal growth using AgNPs/CG. Similarly, several studies demonstrated the suppression of the C. albicans morphogenesis using AgNPs [6,8,53,61] in a mechanism that involved targeting the Ras-mediated signal transduction pathways in C. albicans through the downregulation of the expression of cell elongation gene (Ece1), hyphal inducer gene (Tec), and yeast to hyphal transition genes (Tup1 and Rfg1), which are key genes for the morphological transition [62].
The prevention of blastospore adhesion and differentiation into a filamentous form using AgNPs appears to provide an excellent therapeutic choice [51,63,64,65]. Our results showed that AgNPs/CG was more efficient at suppressing the adhesion and biofilm formation of C. albicans than plant extract or AgNPs alone. Similar to our finding, several other studies demonstrated the inhibitory effect of AgNPs on C. albicans biofilm formation [8,61,66]. In addition, AgNPs biosynthesized by Dodonaea viscosa and Hyptis suoveolens leaf extracts were shown to suppress the biofilm formation of Candida spp. from 79% to 88% at 10 μg/mL [51].
The mechanism underlying the suppression of biofilm formation using AgNPs was reported to include the anti-adhesive action of AgNPs that regulate the growth of living microbial cells and the suppression of microbial adhesions gene expression [27,67,68]. In addition, AgNPs were shown to suppress blastospores and to disrupt the cell wall of both the yeast and the filamentous forms in order to cause the inhibition of biofilm formation in Candida [61,66].
C. albicans has developed enzymatic antioxidant defense mechanisms to reduce the harmful effects of ROS produced by phagocytes during the infection process. Our data demonstrated the inhibitory effect of AgNPs/CG on the production of antioxidant enzymes by C. albicans. Supporting our data, C. gigantea was found to exert an antioxidant activity in other studies [69,70,71]. AgNPs were also reported to display antioxidant activity via stimulating C. albicans to express genes encoding for antioxidants, such as catalase, glutathione peroxidase, superoxide dismutase, and components of the glutathione/glutaredoxin and thioredoxin systems [55,72]. The stimulatory effect of AgNPs on oxidative stress as a mechanism of toxicity in C. albicans resulted in the shifting of the total redox balance to oxidation and thus causing the functional destruction of cells [73,74,75].
Our data demonstrated the safety of using AgNPs/CG at the concentration of (200 µg/mL plant extract + 50 µg/mL AgNPs) in both primary and transformed cultured animal cells, suggesting the plausible application of AgNPs/CG in vivo in a preclinical study. The toxicity of AgNPs to human cells was found to be attributed to the type of the reducing agent used in the biosynthesis [76]. In this regard, the plant extracts could act as a stabilizing agent to stabilize the particles of AgNPs against dissolution, subsequently reducing the toxicity of AgNPs. In addition, the antioxidant and the anti-inflammatory activities of C. gigantean extracts might contribute toward reducing the cytotoxicity of AgNPs [69,70,71].
Thus, the combination of AgNPs and C. gigantean extracts provide a novel strategy for developing biosynthesized-based drug for preventing candidiasis.

5. Conclusions

In this study, we biosynthesized AgNPs by using the aqueous leaf extract of C. gigantean. Our data demonstrated the efficient anti-candidal activity of a combination of biosynthesized AgNPs and the plant extracts of C. gigantean (AgNPs/CG). AgNPs/CG significantly inhibited the growth, morphogenesis, adhesion, biofilm formation, and the secretion of antioxidant defense enzymes by C. albicans. In addition, AgNPs/CG showed no sign of cytotoxicity, even at concentrations higher than the calculated MIC. Thus, AgNPs/CG provides a novel strategy for preventing the pathogenesis of C. albicans by suppressing the key virulence factors and development of biofilms. However, further preclinical studies are needed to evaluate the therapeutic potential of AgNPs/CG in the treatment of candidiasis in vivo.

Availability of Data and Materials

All materials are available from the corresponding author.

Author Contributions

E.M.A. conceived the project, designed the study, performed experiments, analyzed the data, and wrote the manuscript. B.M.A. designed the study, performed experiments, and edited the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the Deanship of Scientific Research at King Faisal University, Saudi Arabia, under Nasher Track (grant no. 186324).

Acknowledgments

The authors acknowledge the Deanship of Scientific Research at King Faisal University, Al-Ahsa for the financial support under Nasher Track (Grant no. 186324).

Conflicts of Interest

The authors declare that they have no competing interests.

References

  1. Gow, N.A.R.; Yadav, B. Microbe Profile: Candida albicans: A shape-changing, opportunistic pathogenic fungus of humans. Microbiology 2017, 163, 1145–1147. [Google Scholar] [CrossRef] [PubMed]
  2. Martins, N.; Ferreira, I.C.; Barros, L.; Silva, S. Henriques M: Candidiasis: Predisposing factors, prevention, diagnosis and alternative treatment. Mycopathologia 2014, 177, 223–240. [Google Scholar] [CrossRef] [PubMed]
  3. Pfaller, M.A.; Diekema, D.J. Epidemiology of invasive candidiasis: A persistent public health problem. Clin. Microbiol. Rev. 2007, 20, 133–163. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Mayer, F.L.; Wilson, D.; Hube, B. Candida albicans pathogenicity mechanisms. Virulence 2013, 4, 119–128. [Google Scholar] [CrossRef] [Green Version]
  5. Marak, M.B.; Dhanashree, B. Antifungal Susceptibility and Biofilm Production of Candida spp. Isolated from Clinical Samples. Int. J. Microbiol. 2018, 2018, 7495218. [Google Scholar] [CrossRef] [Green Version]
  6. Gauwerky, K.; Borelli, C.; Korting, H.C. Targeting virulence: A new paradigm for antifungals. Drug Discov. Today 2009, 14, 214–222. [Google Scholar] [CrossRef]
  7. Taff, H.T.; Mitchell, K.F.; Edward, J.A.; Andes, D.R. Mechanisms of Candida biofilm drug resistance. Future Microbiol. 2013, 8, 1325–1337. [Google Scholar] [CrossRef] [Green Version]
  8. Jalal, M.; Ansari, M.A.; Alzohairy, M.A.; Ali, S.G.; Khan, H.M.; Almatroudi, A.; Siddiqui, M.I. Anticandidal activity of biosynthesized silver nanoparticles: Effect on growth, cell morphology, and key virulence attributes of Candida species. Int. J. Nanomed. 2019, 14, 4667–4679. [Google Scholar] [CrossRef] [Green Version]
  9. Saravanan, M.; Arokiyaraj, S.; Lakshmi, T.; Pugazhendhi, A. Synthesis of silver nanoparticles from Phenerochaete chrysosporium (MTCC-787) and their antibacterial activity against human pathogenic bacteria. Microb. Pathog. 2018, 117, 68–72. [Google Scholar] [CrossRef]
  10. El-Moslamy, S.H. Bioprocessing strategies for cost-effective large-scale biogenic synthesis of nano-MgO from endophytic Streptomyces coelicolor strain E72 as an anti-multidrug-resistant pathogens agent. Sci. Rep. 2018, 8, 3820. [Google Scholar] [CrossRef]
  11. Ovais, M.; Khalil, A.T.; Raza, A.; Khan, M.A.; Ahmad, I.; Islam, N.U.; Saravanan, M.; Ubaid, M.F.; Ali, M.; Shinwari, Z.K. Green synthesis of silver nanoparticles via plant extracts: Beginning a new era in cancer theranostics. Nanomedicine 2016, 11, 3157–3177. [Google Scholar] [CrossRef] [PubMed]
  12. Kadiyala, M.; Ponnusankar, S.; Elango, K. Calotropis gigantiea (L.) R. Br (Apocynaceae): A phytochemical and pharmacological review. J. Ethnopharmacol. 2013, 150, 32–50. [Google Scholar] [CrossRef] [PubMed]
  13. Rabiu Muhammad, A.; Mikaeel Bala, A.; Adamu Bello, K.; Yakubu Umar, D.; Nafiu, L.; Muhammad Bashir, B.; Aminu Yusuf, F. Efficacy and Phytochemical Analysis of Aqueous Extract of Calotropis procera against Selected Dermatophytes. J. Complement Med. Res. 2015, 4, 314. [Google Scholar]
  14. Kumar, G.; Loganathan, K.; Rao, B. Antimicrobial Activity of Latex of Calotropis gigantea Against Pathogenic Microorganisms—An In Vitro Study. Pharmacologyonline 2010, 3, 155–163. [Google Scholar]
  15. Singh, N.; Kannojia, P.; Garud, N.; Pathak, A.; Mehta, S. In vitro antioxidant activity of Calotropis gigantea hydroalcohlic leaves extract. Der Pharmacia Lettre 2010, 2, 95–100. [Google Scholar]
  16. Rajkuberan, C.; Sudha, K.; Sathishkumar, G.; Sivaramakrishnan, S. Antibacterial and cytotoxic potential of silver nanoparticles synthesized using latex of Calotropis gigantea L. Spectrochim. Acta A 2015, 136, 924–930. [Google Scholar] [CrossRef] [PubMed]
  17. Sharma, J.K.; Akhtar, M.S.; Ameen, S.; Srivastava, P.; Singh, G. Green synthesis of CuO nanoparticles with leaf extract of Calotropis gigantea and its dye-sensitized solar cells applications. J. Alloys Compd. 2015, 632, 321–325. [Google Scholar] [CrossRef]
  18. Vaseeharan, B.; Sargunar, C.G.; Lin, Y.C.; Chen, J.C. Green synthesis of Silver nanoparticles through Calotropis gigantea leaf extracts and evaluation of antibacterial activity against Vibrio alginolyticus. Nanotechnol. Dev. 2012, 2, e3. [Google Scholar]
  19. Ali, E.M. Contributions of some biological activities of honey bee venom. J. Apic. Res. 2014, 53, 441–451. [Google Scholar] [CrossRef]
  20. Banerjee, P.; Satapathy, M.; Mukhopahayay, A.; Das, P. Leaf extract mediated green synthesis of silver nanoparticles from widely available Indian plants: Synthesis, characterization, antimicrobial property and toxicity analysis. Bioresour. Bioprocess. 2014, 1, 3. [Google Scholar] [CrossRef] [Green Version]
  21. Jalal, M.; Ansari, M.A.; Shukla, A.K.; Ali, S.G.; Khan Haris, M.; Pal, R.; Alam, J.; Cameotra, S.S. Green synthesis and antifungal activity of Al2O3 NPs against fluconazole-resistant Candida spp isolated from a tertiary care hospital. RSC Adv. 2016, 6, 107577–107590. [Google Scholar] [CrossRef]
  22. Bahrami-Teimoori, B.; Nikparast, Y.; Hojatianfar, M.; Akhlaghi, M.; Ghorbani, R.; Pourianfar, H.R. Characterisation and antifungal activity of silver nanoparticles biologically synthesised by Amaranthus retroflexus leaf extract. J. Exp. Nanosci. 2017, 12, 129–139. [Google Scholar] [CrossRef] [Green Version]
  23. Patra, J.K.; Baek, K.-H. Antibacterial Activity and Synergistic Antibacterial Potential of Biosynthesized Silver Nanoparticles against Foodborne Pathogenic Bacteria along with its Anticandidal and Antioxidant Effects. Front. Microbiol. 2017, 8, 167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Kubo, I.; Fujita, K.; Kubo, A.; Nihei, K.; Ogura, T. Antibacterial activity of coriander volatile compounds against Salmonella choleraesuis. J. Agric. Food Chem. 2004, 52, 3329–3332. [Google Scholar] [CrossRef] [PubMed]
  25. Mangoyi, R.; Midiwo, J.; Mukanganyama, S. Isolation and characterization of an antifungal compound 5-hydroxy-7,4′-dimethoxyflavone from Combretum zeyheri. BMC Complement. Altern. Med. 2015, 15, 405. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Manoharan, R.K.; Lee, J.-H.; Kim, Y.-G.; Lee, J. Alizarin and Chrysazin Inhibit Biofilm and Hyphal Formation by Candida albicans. Front. Cell. Infect. Microbiol. 2017, 7, 447. [Google Scholar] [CrossRef]
  27. Vazquez-Munoz, R.; Avalos-Borja, M.; Castro-Longoria, E. Ultrastructural analysis of Candida albicans when exposed to silver nanoparticles. PLoS ONE 2014, 9, e108876. [Google Scholar] [CrossRef]
  28. Lowry, O.H.; Rosebrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265–275. [Google Scholar]
  29. Habig, W.H.; Pabst, M.J.; Jakoby, W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249, 7130–7139. [Google Scholar]
  30. Teranishi, Y.; Tanaka, A.; Osumi, M.; Fukui, S. Catalase Activities of Hydrocarbon-utilizing Candida Yeasts. Agric. Biol. Chem. 1974, 38, 1213–1220. [Google Scholar] [CrossRef]
  31. McCord, J.M.; Fridovich, I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 1969, 244, 6049–6055. [Google Scholar] [PubMed]
  32. Mohandas, J.; Marshall, J.J.; Duggin, G.G.; Horvath, J.S.; Tiller, D.J. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. Cancer research 1984, 44, 5086–5091. [Google Scholar]
  33. Zaheer, N.; Tewari, K.K.; Krishnan, P.S. Mitochondrial forms of glucose 6-phosphate dehydrogenase and 6-phosphogluconic acid dehydrogenase in rat liver. Arch. Biochem. Biophys. 1967, 120, 22–34. [Google Scholar] [CrossRef]
  34. Shinobu-Mesquita, C.S.; Bonfim-Mendonca, P.S.; Moreira, A.L.; Ferreira, I.C.; Donatti, L.; Fiorini, A.; Svidzinski, T.I. Cellular Structural Changes in Candida albicans Caused by the Hydroalcoholic Extract from Sapindus saponaria L. Molecules 2015, 20, 9405–9418. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Abdallah, B.M.; Alzahrani, A.M.; Abdel-Moneim, A.M.; Ditzel, N.; Kassem, M. A simple and reliable protocol for long-term culture of murine bone marrow stromal (mesenchymal) stem cells that retained their in vitro and in vivo stemness in long-term culture. Biol. Proced. Online 2019, 21, 3. [Google Scholar] [CrossRef] [PubMed]
  36. Kazemi Noureini, S.; Fatemi, L.; Wink, M. Telomere shortening in breast cancer cells (MCF7) under treatment with low doses of the benzylisoquinoline alkaloid chelidonine. PLoS ONE 2018, 13, e0204901. [Google Scholar] [CrossRef] [PubMed]
  37. Abdallah, B.M.; Ali, E.M. 5’-hydroxy Auraptene stimulates osteoblast differentiation of bone marrow-derived mesenchymal stem cells via a BMP-dependent mechanism. J. Biomed. Sci. 2019, 26, 51. [Google Scholar] [CrossRef]
  38. Makarov, V.V.; Love, A.J.; Sinitsyna, O.V.; Makarova, S.S.; Yaminsky, I.V.; Taliansky, M.E.; Kalinina, N.O. “Green” nanotechnologies: Synthesis of metal nanoparticles using plants. Acta Nat. 2014, 6, 35–44. [Google Scholar] [CrossRef] [Green Version]
  39. Chitme, H.R.; Chandra, R.; Kaushik, S. Studies on anti-inflammatory activity of Calotropis gigantea in experimental animals. Asia Pac. J. Pharmacol. 2006, 16, 163. [Google Scholar]
  40. Lhinhatrakool, T.; Sutthivaiyakit, S. 19-Nor- and 18,20-Epoxy-cardenolides from the Leaves of Calotropis gigantea. J. Nat. Prod. 2006, 69, 1249–1251. [Google Scholar] [CrossRef]
  41. Tenpe, C.R.; Upaganlawar, A.B.; Dongre, P.A.; Yeole, P.G. Screening of methanolic extract of Calotropis gigantea leaves for hepatoprotective activity. Indian Drugs 2007, 44, 874–875. [Google Scholar]
  42. Gupta, J.; Sanjrani, M. Rare chemical constituents from Calotropis gigantea roots. Indian J. Pharm. Sci. 2000, 136, 29–32. [Google Scholar]
  43. Kumar, A.; Vemula, P.K.; Ajayan, P.M.; John, G. Silver-nanoparticle-embedded antimicrobial paints based on vegetable oil. Nat. Mater. 2008, 7, 236–241. [Google Scholar] [CrossRef] [PubMed]
  44. Wu, N.; Fu, L.; Su, M.; Aslam, M.; Wong, K.C.; Dravid, V.P. Interaction of Fatty Acid Monolayers with Cobalt Nanoparticles. Nano Lett. 2004, 4, 383–386. [Google Scholar] [CrossRef]
  45. Vilchis-Nestor, A.R.; Sánchez-Mendieta, V.; Camacho-López, M.A.; Gómez-Espinosa, R.M.; Camacho-López, M.A.; Arenas-Alatorre, J.A. Solventless synthesis and optical properties of Au and Ag nanoparticles using Camellia sinensis extract. Mater. Lett. 2008, 62, 3103–3105. [Google Scholar] [CrossRef]
  46. Zhang, W.; Qiao, X.; Chen, J.; Wang, H. Preparation of silver nanoparticles in water-in-oil AOT reverse micelles. J. Colloid Interface Sci. 2006, 302, 370–373. [Google Scholar] [CrossRef] [PubMed]
  47. Nazeruddin, G.M.; Prasad, N.R.; Prasad, S.R.; Shaikh, Y.I.; Waghmare, S.R.; Adhyapak, P. Coriandrum sativum seed extract assisted in situ green synthesis of silver nanoparticle and its anti-microbial activity. Ind. Crops Prod. 2014, 60, 212–216. [Google Scholar] [CrossRef]
  48. Pal, S.; Tak, Y.K.; Song, J.M. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl. Environ. Microbiol. 2007, 73, 1712–1720. [Google Scholar] [CrossRef] [Green Version]
  49. Geffers, C.; Gastmeier, P. Nosocomial infections and multidrug-resistant organisms in Germany: Epidemiological data from KISS (the Hospital Infection Surveillance System). Dtsch. Arzteblatt Online 2011, 108, 87–93. [Google Scholar]
  50. Monteiro, D.R.; Silva, S.; Negri, M.; Gorup, L.F.; de Camargo, E.R.; Oliveira, R.; Barbosa, D.B.; Henriques, M. Silver colloidal nanoparticles: Effect on matrix composition and structure of Candida albicans and Candida glabrata biofilms. J. Appl. Microbiol. 2013, 114, 1175–1183. [Google Scholar] [CrossRef] [Green Version]
  51. Muthamil, S.; Devi, V.A.; Balasubramaniam, B.; Balamurugan, K.; Pandian, S.K. Green synthesized silver nanoparticles demonstrating enhanced in vitro and in vivo antibiofilm activity against Candida spp. J. Basic Microbiol. 2018, 58, 343–357. [Google Scholar] [CrossRef] [PubMed]
  52. Lee, J.H.; Kim, Y.G.; Cho, M.H.; Kim, J.A.; Lee, J. 7-fluoroindole as an antivirulence compound against Pseudomonas aeruginosa. FEMS Microbiol. Lett. 2012, 329, 36–44. [Google Scholar] [CrossRef] [Green Version]
  53. Khatoon, N.; Sharma, Y.; Sardar, M.; Manzoor, N. Mode of action and anti-Candida activity of Artemisia annua mediated-synthesized silver nanoparticles. J. Mycol. Méd. 2019, 29, 201–209. [Google Scholar] [CrossRef] [PubMed]
  54. Kim, K.-J.; Sung, W.S.; Suh, B.K.; Moon, S.-K.; Choi, J.-S.; Kim, J.G.; Lee, D.G. Antifungal activity and mode of action of silver nano-particles on Candida albicans. BioMetals 2009, 22, 235–242. [Google Scholar] [CrossRef] [PubMed]
  55. Dantas Ada, S.; Day, A.; Ikeh, M.; Kos, I.; Achan, B.; Quinn, J. Oxidative stress responses in the human fungal pathogen, Candida albicans. Biomolecules 2015, 5, 142–165. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Habib, M.; Karim, M. Antimicrobial and Cytotoxic Activity of Di-(2-ethylhexyl) Phthalate and Anhydrosophoradiol-3-acetate Isolated from Calotropis gigantea (Linn.) Flower. Mycobiology 2009, 37, 31–36. [Google Scholar] [CrossRef] [Green Version]
  57. Pattnaik, P.K.; Kar, D.; Chhatoi, H.; Shahbazi, S.; Ghosh, G.; Kuanar, A. Chemometric profile & antimicrobial activities of leaf extract of Calotropis procera and Calotropis gigantea. Nat. Prod. Res. 2017, 31, 1954–1957. [Google Scholar]
  58. Peters, B.M.; Palmer, G.E.; Nash, A.K.; Lilly, E.A.; Fidel, P.L.; Noverr, M.C., Jr. Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis. Infect. Immun. 2014, 82, 532–543. [Google Scholar] [CrossRef] [Green Version]
  59. Carradori, S.; Chimenti, P.; Fazzari, M.; Granese, A.; Angiolella, L. Antimicrobial activity, synergism and inhibition of germ tube formation by Crocus sativus-derived compounds against Candida spp. J. Enzyme Inhib. Med. Chem. 2016, 31, 189–193. [Google Scholar] [CrossRef] [Green Version]
  60. Modrzewska, B.; Kurnatowski, P. Adherence of Candida sp. to host tissues and cells as one of its pathogenicity features. Ann. Parasitol. 2015, 61, 3–9. [Google Scholar]
  61. Rozalska, B.; Sadowska, B.; Budzynska, A.; Bernat, P.; Rozalska, S. Biogenic nanosilver synthesized in Metarhizium robertsii waste mycelium extract—As a modulator of Candida albicans morphogenesis, membrane lipidome and biofilm. PLoS ONE 2018, 13, e0194254. [Google Scholar] [CrossRef] [PubMed]
  62. Halbandge, S.D.; Jadhav, A.K.; Jangid, P.M.; Shelar, A.V.; Patil, R.H.; Karuppayil, S.M. Molecular targets of biofabricated silver nanoparticles in Candida albicans. J. Antibiot. 2019, 72, 640–644. [Google Scholar] [CrossRef] [PubMed]
  63. Jacobsen, I.D.; Wilson, D.; Wachtler, B.; Brunke, S.; Naglik, J.R.; Hube, B. Candida albicans dimorphism as a therapeutic target. Expert Rev. Anti-Infect. Ther. 2012, 10, 85–93. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Lemire, J.A.; Harrison, J.J.; Turner, R.J. Antimicrobial activity of metals: Mechanisms, molecular targets and applications. Nat. Rev. Microbiol. 2013, 11, 371–384. [Google Scholar] [CrossRef]
  65. Vila, T.; Romo, J.A.; Pierce, C.G.; McHardy, S.F.; Saville, S.P.; Lopez-Ribot, J.L. Targeting Candida albicans filamentation for antifungal drug development. Virulence 2017, 8, 150–158. [Google Scholar] [CrossRef] [Green Version]
  66. Lara, H.H.; Romero-Urbina, D.G.; Pierce, C.; Lopez-Ribot, J.L.; Arellano-Jimenez, M.J.; Jose-Yacaman, M. Effect of silver nanoparticles on Candida albicans biofilms: An ultrastructural study. J. Nanobiotechnol. 2015, 13, 91. [Google Scholar] [CrossRef] [Green Version]
  67. Gulati, M.; Nobile, C.J. Candida albicans biofilms: Development, regulation, and molecular mechanisms. Microbes Infect. 2016, 18, 310–321. [Google Scholar] [CrossRef] [Green Version]
  68. Sardi, J.C.; Scorzoni, L.; Bernardi, T.; Fusco-Almeida, A.M.; Mendes Giannini, M.J. Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J. Med. Microbiol. 2013, 62, 10–24. [Google Scholar] [CrossRef]
  69. Patel, H.; Patel, J.; Patel, B. Comparative efficacy of phytochemical analysis and antioxidant activity of methanolic extract of calotropis gigantea and calotropis procera. Int. J. Biol. Pharm. Res. 2014, 5, 107–113. [Google Scholar]
  70. Rathod, N.R.; Raghuveer, I.; Chitme, H.R.; Chandra, R. Free Radical Scavenging Activity of Calotropis gigantea on Streptozotocin-Induced Diabetic Rats. Indian J. Pharm. Sci. 2009, 71, 615–621. [Google Scholar] [CrossRef] [Green Version]
  71. Singh, N.; Pathak, A.K.; Tailang, M. Phytochemistry and evaluation of antioxidant activity of whole plant of Calotropis gigantea Linn. Int. J. Res. Ayurveda Pharm. 2010, 1, 120–125. [Google Scholar]
  72. Zhang, X.F.; Liu, Z.G.; Shen, W.; Gurunathan, S. Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches. Int. J. Mol. Sci. 2016, 17, 9. [Google Scholar] [CrossRef] [PubMed]
  73. Arora, S.; Jain, J.; Rajwade, J.M.; Paknikar, K.M. Cellular responses induced by silver nanoparticles: In vitro studies. Toxicol. Lett. 2008, 179, 93–100. [Google Scholar] [CrossRef] [PubMed]
  74. Liao, S.; Zhang, Y.; Pan, X.; Zhu, F.; Jiang, C.; Liu, Q.; Cheng, Z.; Dai, G.; Wu, G.; Wang, L.; et al. Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant Pseudomonas aeruginosa. Int. J. Nanomed. 2019, 14, 1469–1487. [Google Scholar] [CrossRef] [Green Version]
  75. Yuan, Y.-G.; Peng, Q.-L.; Gurunathan, S. Effects of Silver Nanoparticles on Multiple Drug-Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa from Mastitis-Infected Goats: An Alternative Approach for Antimicrobial Therapy. Int. J. Mol. Sci. 2017, 18, 569. [Google Scholar] [CrossRef] [Green Version]
  76. Asharani, P.V.; Lian Wu, Y.; Gong, Z.; Valiyaveettil, S. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology 2008, 19, 255102. [Google Scholar] [CrossRef]
Nanomaterials 10 00422 g001 550
Figure 1. Synthesis of AgNPs from the leaf extract of Calotropis gigantean (CG). (A) Candida albicans isolated from sputum samples, cultured on Sabouraud’s dextrose agar (SDA). (B) Silver nitrate solution before (A) and after (B) the synthesis of AgNPs from the leaf extract of C. gigantean.
Figure 1. Synthesis of AgNPs from the leaf extract of Calotropis gigantean (CG). (A) Candida albicans isolated from sputum samples, cultured on Sabouraud’s dextrose agar (SDA). (B) Silver nitrate solution before (A) and after (B) the synthesis of AgNPs from the leaf extract of C. gigantean.
Nanomaterials 10 00422 g001
Nanomaterials 10 00422 g002 550
Figure 2. Characterization of AgNPs synthesized by C. gigantean in aqueous solution. (A) UV-vis absorption spectrum of synthesized AgNPs by a C. gigantean leaf extract incubated with silver nitrate (1 mM). The peak values are for the UV-vis plotted between AgNPs/absorbance ratios. The highest absorbance peak was at about 450 nm, corresponding to the plasmon resonance of AgNPs. (B) XRD spectrum recorded for AgNPs showed four distinct diffraction peaks at 38.18°, 44.35°, 64.4°, and 77.3° indexed 20(degree) values of (111), (200), (220), and (311) crystalline planes of cubic Ag.
Figure 2. Characterization of AgNPs synthesized by C. gigantean in aqueous solution. (A) UV-vis absorption spectrum of synthesized AgNPs by a C. gigantean leaf extract incubated with silver nitrate (1 mM). The peak values are for the UV-vis plotted between AgNPs/absorbance ratios. The highest absorbance peak was at about 450 nm, corresponding to the plasmon resonance of AgNPs. (B) XRD spectrum recorded for AgNPs showed four distinct diffraction peaks at 38.18°, 44.35°, 64.4°, and 77.3° indexed 20(degree) values of (111), (200), (220), and (311) crystalline planes of cubic Ag.
Nanomaterials 10 00422 g002
Nanomaterials 10 00422 g003 550
Figure 3. FTIR spectrum and TEM of AgNPs synthesized by C. gigantean. (A) The FTIR spectrum of the synthesized AgNPs from C. gigantean leaf showing seven distinct peaks at 1116, 1457, 1629, 2361, 2853, 2923, and 3421 cm−1, revealing the existence of amide, amino, and alkane groups. This proved the availability of abundant chemical constituents that had bound onto the synthesized AgNPs. (B) A TEM image showing the spherical shape nanoparticles, where the size was in the range of ≈10–70 nm. The AgNPs were distributed uniformly without significant agglomeration.
Figure 3. FTIR spectrum and TEM of AgNPs synthesized by C. gigantean. (A) The FTIR spectrum of the synthesized AgNPs from C. gigantean leaf showing seven distinct peaks at 1116, 1457, 1629, 2361, 2853, 2923, and 3421 cm−1, revealing the existence of amide, amino, and alkane groups. This proved the availability of abundant chemical constituents that had bound onto the synthesized AgNPs. (B) A TEM image showing the spherical shape nanoparticles, where the size was in the range of ≈10–70 nm. The AgNPs were distributed uniformly without significant agglomeration.
Nanomaterials 10 00422 g003
Nanomaterials 10 00422 g004 550
Figure 4. Antimicrobial potential of AgNPs. (A) Disc diffusion method showing the anti-candidal activity of AgNPs and the synergistic anti-candidal potential of AgNPs (50 µg/mL) mixed with C. gigantea leaf extract (200 µg/mL). Data are expressed as the mean zone of inhibition in mm. (B) Time-kill curves of C. albicans following exposure to AgNPs, plant extract, and AgNPs/CG. Non-treated Candida cells were used as a control. There was a decrease in the rate of cell growth when Candida cells were treated with AgNPs/CG compared to either the control cells, AgNPs alone, or plant extract alone. Values are the mean ± SD of three independent experiments.
Figure 4. Antimicrobial potential of AgNPs. (A) Disc diffusion method showing the anti-candidal activity of AgNPs and the synergistic anti-candidal potential of AgNPs (50 µg/mL) mixed with C. gigantea leaf extract (200 µg/mL). Data are expressed as the mean zone of inhibition in mm. (B) Time-kill curves of C. albicans following exposure to AgNPs, plant extract, and AgNPs/CG. Non-treated Candida cells were used as a control. There was a decrease in the rate of cell growth when Candida cells were treated with AgNPs/CG compared to either the control cells, AgNPs alone, or plant extract alone. Values are the mean ± SD of three independent experiments.
Nanomaterials 10 00422 g004
Nanomaterials 10 00422 g005 550
Figure 5. Effect of AgNPs on virulence factors of C. albicans. (A) Microscopic examination of the dimorphic transition in RPMI-1640 medium supplemented with either amphotericine b, AgNPs, or AgNPs/CG. Complete inhibition of the dimorphic transition (all cells were observed in yeast form when AgNPs and plant extract were combined, unlike when the two were tested on their own). (B) Percentage of adhesion after (2 h) in RPMI-1640 medium supplemented with 0.25% glucose. (C) Biofilm formation (after 24 h) as measured using an MTT metabolic assay. Values are the mean ± SD of three independent experiments (* p < 0.05, ** p < 0.005).
Figure 5. Effect of AgNPs on virulence factors of C. albicans. (A) Microscopic examination of the dimorphic transition in RPMI-1640 medium supplemented with either amphotericine b, AgNPs, or AgNPs/CG. Complete inhibition of the dimorphic transition (all cells were observed in yeast form when AgNPs and plant extract were combined, unlike when the two were tested on their own). (B) Percentage of adhesion after (2 h) in RPMI-1640 medium supplemented with 0.25% glucose. (C) Biofilm formation (after 24 h) as measured using an MTT metabolic assay. Values are the mean ± SD of three independent experiments (* p < 0.05, ** p < 0.005).
Nanomaterials 10 00422 g005
Nanomaterials 10 00422 g006 550
Figure 6. Ultrastructure alteration in C. albicans by AgNPs/CG. TEM images of C. albicans cells treated with AgNPs. (A) Yeasts without treatment showing the typical filamentous morphology of C. albicans, which was very elongated but narrow in width (0.6–1.1 µm). (B) Yeast after treatment showing the typical C. albicans yeast form morphology, where the ovoid cell was surrounded by a cell wall after 24 h of incubation and treatment with AgNPs/CG (50 µg/mL AgNPs + 200 µg/mL plant extract).
Figure 6. Ultrastructure alteration in C. albicans by AgNPs/CG. TEM images of C. albicans cells treated with AgNPs. (A) Yeasts without treatment showing the typical filamentous morphology of C. albicans, which was very elongated but narrow in width (0.6–1.1 µm). (B) Yeast after treatment showing the typical C. albicans yeast form morphology, where the ovoid cell was surrounded by a cell wall after 24 h of incubation and treatment with AgNPs/CG (50 µg/mL AgNPs + 200 µg/mL plant extract).
Nanomaterials 10 00422 g006
Nanomaterials 10 00422 g007 550
Figure 7. Cytotoxicity of AgNPs, plant extract and AgNPs/CG on animal cell culture. MCF-7 and mBMSCs cells were treated with different concentrations of (A) AgNPs, (B) plant extract, or (C) AgNPs/CG (50 µg/mL + different concentrations of C. gigantean) for 24 h, where cytotoxicity was measured using an MTT assay. Values are the mean ± SD (error bars) of three independent experiments (* p < 0.05, ** p < 0.005 compared to the control non-treated cell line).
Figure 7. Cytotoxicity of AgNPs, plant extract and AgNPs/CG on animal cell culture. MCF-7 and mBMSCs cells were treated with different concentrations of (A) AgNPs, (B) plant extract, or (C) AgNPs/CG (50 µg/mL + different concentrations of C. gigantean) for 24 h, where cytotoxicity was measured using an MTT assay. Values are the mean ± SD (error bars) of three independent experiments (* p < 0.05, ** p < 0.005 compared to the control non-treated cell line).
Nanomaterials 10 00422 g007
Table
Table 1. Anti-candidal activity of AgNPs and plant extract against C. albicans.
Table 1. Anti-candidal activity of AgNPs and plant extract against C. albicans.
Concentration
(µg/mL)		Antifungal Agents
Amphotericine BAgNPsPlant Extract
IZD (mm)
00 a ± 0.20 a ± 1.00 a ± 0.2
6.2519 c ± 0.26 b ± 1.23.6 a ± 0.8
12.5No growth8.22 b ± 0.54.1 a ± 1.0
2511.33 b ± 0.94.9 a ± 1.5
50No growth5.2 a ± 1.5
1006.1 a ± 0.9
200No growth
400
IZD: Inhibition zone diameter (mm). Data are expressed as the mean zone of inhibition in mm followed by SD. The values with different superscript letters (a, b and c) in the same row are significantly different according to ANOVA and Duncan’s multiple range tests.
Table
Table 2. Specific activities of antioxidant enzymes.
Table 2. Specific activities of antioxidant enzymes.
EnzymeSubstrateSpecific Activity (U/mg Protein)
ControlAgNPs/CG
Glutathone-S transferaseCDNB0.422 ± 0.110.0602
CatalaseH2O22.3 ± 0.330.75
Superoxide dismutaseEpinephrine0.405 ± 0.060.0675
Glucose 6 phosphate dehydrogenaseNADP425.22 ± 5.1153.15
Glutathione reductaseNADPH45.23 ± 2.136.46
Glutathione peroxidaseNADPH0.00055 ± 0.00010

Share and Cite

MDPI and ACS Style

Ali, E.M.; Abdallah, B.M. Effective Inhibition of Candidiasis Using an Eco-Friendly Leaf Extract of Calotropis-gigantean-Mediated Silver Nanoparticles. Nanomaterials 2020, 10, 422. https://doi.org/10.3390/nano10030422

AMA Style

Ali EM, Abdallah BM. Effective Inhibition of Candidiasis Using an Eco-Friendly Leaf Extract of Calotropis-gigantean-Mediated Silver Nanoparticles. Nanomaterials. 2020; 10(3):422. https://doi.org/10.3390/nano10030422

Chicago/Turabian Style

Ali, Enas M., and Basem M. Abdallah. 2020. "Effective Inhibition of Candidiasis Using an Eco-Friendly Leaf Extract of Calotropis-gigantean-Mediated Silver Nanoparticles" Nanomaterials 10, no. 3: 422. https://doi.org/10.3390/nano10030422

APA Style

Ali, E. M., & Abdallah, B. M. (2020). Effective Inhibition of Candidiasis Using an Eco-Friendly Leaf Extract of Calotropis-gigantean-Mediated Silver Nanoparticles. Nanomaterials, 10(3), 422. https://doi.org/10.3390/nano10030422

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop